COVID-19 Genomics UK Consortium

COG-UK is a pioneer in the use of large-scale, rapid whole-genome sequencing of SARS-CoV-2, the virus causing the COVID-19 pandemic, to understand viral transmission and evolution, and to inform public health responses and vaccine development.

News & Twitter

Latest Updates

Blog

22 Dec 2021

“COVID must not distract us from the fight for equality” – in conversation with Sir Jeremy Farrar

In the final ‘Women in COG’ event of 2021, Director of the Wellcome Trust Sir Jeremy Farrar tells COG-UK Executive Director Professor Sharon Peacock why diversity and inclusion must return to the top of the agenda.

Blog

16 Dec 2021

Reflections on 2021 for COG-UK

Last year’s festive period feels like light years ago, such is the impact of COVID-19 where much can change in what feels like the blink of an eye.

Blog

30 Nov 2021

Tracking SARS-CoV-2 evolution and remdesivir treatment in hospital patients

A recent study has used genomic sequencing of the SARS-CoV-2 virus to help understand how the virus evolves in hospital patients and learn more about the antiviral drug remdesivir.

Our Partners

Powering pathogen genomics through partnership

We work collaboratively to catalyze SARS-CoV-2 genomic research, data linkage, and training, providing data that influences public health interventions and policy decisions, and thereby make a contribution towards reducing the toll of COVID-19 on our population.

Led by Professor Sharon Peacock of the University of Cambridge, COG-UK is made up of an innovative partnership of NHS organisations, public health agencies, academic partners providing sequencing and analysis capacity, Lighthouse Labs, and the central sequencing hub of the Wellcome Sanger Institute.

Total UK SARS-CoV-2 genomes sequenced